Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 16, Issue 8, 2001, Pages 1669-1674

  Espinosa, Mario ^a   Martin Malo, Alejandro ^a   De Lara, Maria Antonia Alvarez ^a   Aljama, Pedro ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Cirrhosis; Death; Haemodialysis; Hepatitis C virus; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC LIVER DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MODEL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL; TIME; TREATMENT OUTCOME;

EID: 0034877859     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.8.1669     Document Type: Article

References (33)

1. The impact of hepatitis C virus infection on renal allograft recipients
2. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation
3. Hepatitis C virus infection among kidney transplant recipients
4. The long-term course of hepatitis C after kidney transplantation
5. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection
6. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease
7. Impact of hepatitis B and C virus on kidney transplantation outcome
8. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
9. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years
10. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus
11. Risk of death among chronic dialysis patients infected with hepatitis C virus
12. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: A clinical and histologic evaluation of 242 cases
13. The natural history of asymptomatic hepatitis B surface antigen carriers
14. Hepatitis B surface antigenemia in a chronic hemodialysis program: Lack of influence on morbidity and mortality
15. The long-term outcome of hepatitis B infection in hemodialysis patients
16. High ALT levels predict viremia in anti-HCV positive HD patients if a modified normal range of ALT is applied
17. Clinical outcomes after transfusion-associated hepatitis C
18. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
19. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
20. Survival analysis of dialysis patients in Okinawa, Japan (1971-1990)
21. Liver histology in chronic hemodialysis patients infected with hepatitis C virus
22. Liver disease in dialysis patients with antibodies to hepatitis C virus
23. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus
24. Natural history of hepatitis C
25. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
26. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease
27. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients
28. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: A systematic quantitative overview of the literature
29. Abysmal prognosis of patients with type 2 diabetes entering dialysis
30. Long-term mortality after transfusion-associated non-A, non-B hepatitis
31. Abnormalities of neutrophil phagocytosis, intracellular killing, metabolic activity in alcoholic cirrhosis, hepatitis
32. Impaired function of macrophage Fc gamma receptors in end-stage renal disease
33. Host defenses and immunologic alterations associated with chronic hemodialysis